Covid-19 roundup: No­vavax shakes up lead­er­ship with two pro­mo­tions and de­par­ture of CFO; Mod­er­na, No­vavax shots added to mix-and-match study in the UK

No­vavax has had a busy month, filled with sup­ply chain is­sues and man­u­fac­tur­ing deals that have af­fect­ed the roll­out of its Covid-19 vac­cine. Tues­day, the com­pa­ny an­nounced up­dates to its lead­er­ship team.

CFO Greg Covi­no will step down from that role af­ter just five months for per­son­al rea­sons, the re­lease said, but take on a new role as ex­ec­u­tive ad­vi­sor. John Trizzi­no, cur­rent chief com­mer­cial of­fi­cer and chief busi­ness of­fi­cer, will take the CFO role over in the in­ter­im.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER